UnitedHealth Group (NYSE:UNH) Stock Price Down 1% – What’s Next?

Shares of UnitedHealth Group Incorporated (NYSE:UNH) dropped 1% on Friday. The company traded as low as $405.91 and last traded at $406.67. 4,292,451 shares were traded during mid-day trading, a decline of 41% from the average session volume of 7,261,615 shares. The stock had previously closed at $410.91.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Improving margins and higher price target: Morgan Stanley said UnitedHealth’s margins are recovering, with Medicare operations returning to a more normal range, and raised its price target. However, commercial insurance, Medicaid and increased AI-related spending remain important execution tests. UnitedHealth is bouncing back, but a major risk remains
• Positive Sentiment: Recent earnings beat and raised guidance: UnitedHealth’s latest quarterly results exceeded expectations for both earnings and revenue, and the company raised its outlook. The earnings recovery supports the case that operating performance is stabilizing after earlier pressure. Why Did UnitedHealth Raise Guidance After Its Quarterly Beat?
• Positive Sentiment: Dividend appeal: UnitedHealth is highlighted as a major healthcare dividend payer, potentially supporting demand from income-focused investors. The article also cautions that dividend safety should be assessed alongside payout sustainability and business risks. $250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends
• Neutral Sentiment: Analyst estimates are mixed: Zacks Research maintained a “Hold” rating and projects roughly $20.54 in FY2026 EPS, close to the broader consensus near $20.62. It raised several longer-term quarterly estimates but lowered others, including Q1 2027, Q1 2028 and Q2 2028.
• Negative Sentiment: Near-term earnings pressure: Zacks Research issued a negative estimate for fourth-quarter earnings, adding to concerns that high medical utilization and costs could limit profitability despite the Medicare recovery. Zacks Research Has Negative Estimate for UNH Q4 Earnings

Analyst Ratings Changes

A number of equities research analysts recently commented on UNH shares. Leerink Partners lifted their target price on UnitedHealth Group from $462.00 to $472.00 and gave the stock an “outperform” rating in a report on Friday, July 17th. Morgan Stanley increased their price target on shares of UnitedHealth Group from $529.00 to $531.00 and gave the stock an “overweight” rating in a report on Tuesday. Truist Financial raised their price target on shares of UnitedHealth Group from $440.00 to $480.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Royal Bank Of Canada lifted their price objective on shares of UnitedHealth Group from $478.00 to $498.00 and gave the company an “outperform” rating in a research note on Tuesday, October 20th. Finally, Bank of America reiterated a “buy” rating and issued a $450.00 price objective on shares of UnitedHealth Group in a research note on Monday, July 20th. Twenty analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $463.93.

UnitedHealth Group Trading Down 1.0%

The firm has a market cap of $365.02 billion, a price-to-earnings ratio of 23.23, a price-to-earnings-growth ratio of 1.47 and a beta of 0.60. The company’s 50-day moving average price is $389.76 and its 200-day moving average price is $362.07. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping the consensus estimate of $4.14 by $0.55. The firm had revenue of $112.70 billion during the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company’s revenue for the quarter was down .4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date was Monday, September 14th. UnitedHealth Group’s payout ratio is 53.00%.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.19% of the stock is owned by insiders.

Institutional Trading of UnitedHealth Group

Several large investors have recently made changes to their positions in the company. City State Bank boosted its position in UnitedHealth Group by 5.6% during the third quarter. City State Bank now owns 471 shares of the healthcare conglomerate’s stock worth $173,000 after acquiring an additional 25 shares during the last quarter. Murphy Pohlad Asset Management LLC raised its holdings in UnitedHealth Group by 0.5% in the 3rd quarter. Murphy Pohlad Asset Management LLC now owns 5,305 shares of the healthcare conglomerate’s stock valued at $1,947,000 after acquiring an additional 25 shares during the last quarter. Synergy Financial Group LTD lifted its stake in UnitedHealth Group by 3.1% in the 2nd quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate’s stock worth $369,000 after purchasing an additional 27 shares in the last quarter. LFG Wealth Partners LLC boosted its holdings in shares of UnitedHealth Group by 3.3% during the 2nd quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate’s stock worth $355,000 after purchasing an additional 27 shares during the last quarter. Finally, Ares Financial Consulting LLC boosted its holdings in shares of UnitedHealth Group by 7.2% during the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock worth $174,000 after purchasing an additional 28 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.